1,234
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

A nationwide evaluation of antibiotics consumption in Swedish intensive care units

ORCID Icon, , &
Pages 713-721 | Received 10 Mar 2022, Accepted 18 May 2022, Published online: 30 May 2022

Figures & data

Table 1. Antibiotic consumption in Swedish ICUs 2016–2018.

Figure 1. Individual hospital DDDs per 100 OBDs.

Figure 1. Individual hospital DDDs per 100 OBDs.

Figure 2. Descending frequency of antibiotic classes used during the years 2016–2018.

Figure 2. Descending frequency of antibiotic classes used during the years 2016–2018.

Figure 3. DDDs per 100 OBD of all antibiotic classes according to hospital category. Mean of 2016–2018.

Figure 3. DDDs per 100 OBD of all antibiotic classes according to hospital category. Mean of 2016–2018.

Figure 4. Relative use of broad-spectrum (J01DH + J01CR + J01DD_DE + J01MA) antibiotics to all antibiotics (J01). Arranged according to hospital category.

Figure 4. Relative use of broad-spectrum (J01DH + J01CR + J01DD_DE + J01MA) antibiotics to all antibiotics (J01). Arranged according to hospital category.

Figure 5. (a) Carbapenem use in relation to total antibiotic use (J01DH/J01). (b) Aminoglycoside use in relation to total antibiotic use (J01GB/J01).

Note. Dashed line indicates the median.

Figure 5. (a) Carbapenem use in relation to total antibiotic use (J01DH/J01). (b) Aminoglycoside use in relation to total antibiotic use (J01GB/J01).Note. Dashed line indicates the median.